TY  - JOUR
T1  - Prevalence of Risk Elements, Severity Assessment and Treatment Outcomes of Stroke – A Prospective Observational Study
A1  - Sreenu Thalla
A1  - Harsheenee Bellamkonda
A1  - Shaik Tanisha Bibi
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2021
VL  - 11
IS  - 3
DO  - 10.51847/YnDYeUH3UG
SP  - 15
EP  - 20
N2  - Stroke is the third major cause of death worldwide and is a major public health challenge in society. 15 million people suffer from it each year, and one-third is left permanently disabled one-third die worldwide. The average age of onset is above 55 years in western studies which were also found similar in the Indian population. There is a male predominance ratio of approximately 5:1. This study was conducted in Neurology Department at New Government General Hospital, Vijayawada.165 patients were selected out of 152 were selected with the positive response of males and females of the Neurology department. The majority of patients were affected with lower limb weakness 106. Majority of patients were consuming alcohol were 105, [male-104, female-1], followed by smoking 97, [males-87, females-10]. The majority of patients had hypertension as a major risk factor 111, diabetes 92, Hyperlipidemia 90, seizures 66 patients. CT showed clots were in majority 127 than those who had haemorrhage 25. The majority of drugs given to stroke patients are antiplatelets, antihypertensives, Dyslipidemics and antibiotics were. Aspirin was the majorly used drug in a maximum number of 138, followed by Atorvastatin 131, Clopidogrel 113, Citicoline 119. Assessment done by Glasgow Coma Scale had the majority of patients were with moderate scoring 79 [males-60, females-19]. Assessment Done by NIHSS Scale had the majority of patients were under the moderate-severe category 79 [males-63, females-16]. 
UR  - https://eijppr.com/article/prevalence-of-risk-elements-severity-assessment-and-treatment-outcomes-of-stroke-a-prospective-ob-ohld7thhgfv5dig
ER  -